i-SENS Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Public

  • Employees
  • 887

Employees

  • Stock Symbol
  • 099190

Stock Symbol

  • Investments
  • 8

  • Share Price
  • $11.65
  • (As of Tuesday Closing)

i-SENS General Information

Description

i-SENS Inc is a Korean company which is engaged in the manufacture and sale of biosensors. The product portfolio of the company includes blood glucose monitoring systems, including blood glucose monitors, blood glucose meters, glucose monitors, blood glucose meter kits and blood sugar meters under the brand names of CareSens, MedTrust, BGStar, Barozen and others.

Contact Information

Website
www.i-sens.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 43, Banpo-daero 28-gil
  • Seoul, Seocho-gu 06646
  • South Korea
+82
Primary Industry
Monitoring Equipment
Other Industries
Other Devices and Supplies
Stock Exchange
KRX
Vertical(s)
Manufacturing
Corporate Office
  • 43, Banpo-daero 28-gil
  • Seoul, Seocho-gu 06646
  • South Korea
+82

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

i-SENS Stock Performance

As of 11-Feb-2025, i-SENS’s stock price is $11.65. Its current market cap is $322M with 27.6M shares.

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$11.65 $12.17 $10.08 - $17.80 $322M 27.6M 142K -$0.05

i-SENS Financials Summary

As of 30-Sep-2024, i-SENS has a trailing 12-month revenue of $212M.

In Thousands,
USD 		TTM 30-Sep-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 432,184 684,868 386,784 359,541
Revenue 211,643 202,777 204,964 203,362
EBITDA 14,043 15,835 23,959 35,496
Net Income (1,361) 2,837 12,490 22,220
Total Assets 419,578 387,075 355,980 360,649
Total Debt 133,211 111,580 79,858 84,766
Public Fundamental Data provided by Morningstar, Inc. disclaimer

i-SENS Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore i-SENS‘s full profile, request access.

Request a free trial

i-SENS Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
i-SENS Inc is a Korean company which is engaged in the manufacture and sale of biosensors. The product portfolio of the
Monitoring Equipment
Seoul, South Korea
887 As of 2024

Gent, Belgium
 

Berlin, Germany
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

i-SENS Competitors (2)

One of i-SENS’s 2 competitors is Indigo (Monitoring Equipment), a Venture Capital-Backed company based in Gent, Belgium.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Indigo (Monitoring Equipment) Venture Capital-Backed Gent, Belgium
DiaMonTech Venture Capital-Backed Berlin, Germany
You’re viewing 2 of 2 competitors. Get the full list »

i-SENS Patents

  • 845

    Total Documents Applications and Grants

  • Total Patents Families

  • 430

    Granted

  • 321

    Pending

  • Expiring in next 12 mo

i-SENS Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240415420-A1 Method of providing behavioral information for controlling glucose level, device for performing the same, and analyte monitoring system Pending 14-Jun-2023
EP-4477146-A1 Method of providing behavioral information for controlling glucose level, device for performing the same, and analyte monitoring system Pending 14-Jun-2023
US-20240415421-A1 Method for calibrating sensitivity for glucose measurement Pending 13-Jun-2023
EP-4477147-A1 Method for calibrating sensitivity for glucose measurement Pending 13-Jun-2023
AU-2024204000-A1 Method for calibrating sensitivity for glucose measurement Pending 13-Jun-2023 A61B5/14532
To view i-SENS’s complete patent history, request access »

i-SENS Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

i-SENS Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore i-SENS‘s full profile, request access.

Request a free trial

i-SENS Investments & Acquisitions (8)

i-SENS’s most recent deal was a Later Stage VC with CareMedi for . The deal was made on 06-Nov-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
CareMedi 06-Nov-2023 Later Stage VC Therapeutic Devices
WaveForm Diabetes 01-Jun-2023 Merger/Acquisition Monitoring Equipment
CareMedi 31-Jan-2022 Later Stage VC Therapeutic Devices
G2e 01-Nov-2021 Later Stage VC Monitoring Equipment
Zentry (Monitoring Equipment) 04-Jan-2021 Accelerator/Incubator Monitoring Equipment
You’re viewing 5 of 8 investments and acquisitions. Get the full list »

i-SENS ESG

Risk Overview

Risk Rating

Updated October, 22, 2023

32.47 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 15,120

Rank

Percentile

Healthcare

Industry

of 587

Rank

Percentile

Medical Devices

Subindustry

of 199

Rank

Percentile

To view i-SENS’s complete esg history, request access »

i-SENS Exits (2)

i-SENS’s most recent exit was on 01-Jun-2023 from WaveForm Diabetes. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
WaveForm Diabetes 01-Jun-2023 Completed
Mendor 31-Mar-2016 PE Growth/Expansion Completed
  • 3 buyers
To view i-SENS’s complete exits history, request access »

Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Coag-Sense Fremont, CA 2008

i-SENS FAQs

  • When was i-SENS founded?

    i-SENS was founded in 2000.

  • Where is i-SENS headquartered?

    i-SENS is headquartered in Seoul, South Korea.

  • What is the size of i-SENS?

    i-SENS has 887 total employees.

  • What industry is i-SENS in?

    i-SENS’s primary industry is Monitoring Equipment.

  • Is i-SENS a private or public company?

    i-SENS is a Public company.

  • What is i-SENS’s stock symbol?

    The ticker symbol for i-SENS is 099190.

  • What is the current stock price of i-SENS?

    As of 11-Feb-2025 the stock price of i-SENS is $11.65.

  • What is the current market cap of i-SENS?

    The current market capitalization of i-SENS is $322M.

  • What is i-SENS’s current revenue?

    The trailing twelve month revenue for i-SENS is $212M.

  • Who are i-SENS’s competitors?

    Indigo (Monitoring Equipment) and DiaMonTech are competitors of i-SENS.

  • What is i-SENS’s annual earnings per share (EPS)?

    i-SENS’s EPS for 12 months was -$0.05.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »